16033898|t|Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
16033898|a|Amyloid-beta (Abeta), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different second-messenger cascades. Interestingly, Abeta has been found to markedly impair hippocampal long-term potentiation (LTP). To identify a new pathway that might be responsible for such impairment, we analyzed the role of the nitric oxide (NO)/soluble guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP. The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Abeta-induced impairment of CA1-LTP through cGK activation. Furthermore, these compounds reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Abeta. We also found that Abeta blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Abeta. These results strongly suggest that, when modulating hippocampal synaptic plasticity, Abeta downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated production of Abeta.
16033898	154	166	Amyloid-beta	Gene	351
16033898	168	173	Abeta	Gene	351
16033898	220	239	Alzheimer's disease	Disease	MESH:D000544
16033898	241	243	AD	Disease	MESH:D000544
16033898	339	344	Abeta	Gene	351
16033898	522	534	nitric oxide	Chemical	MESH:D009569
16033898	607	610	cGK	Gene	5592
16033898	653	657	CREB	Gene	1385
16033898	726	786	2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt	Chemical	-
16033898	788	794	DEA/NO	Chemical	-
16033898	816	902	3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine	Chemical	MESH:C423582
16033898	911	915	cGMP	Chemical	MESH:D006152
16033898	924	936	8-bromo-cGMP	Chemical	MESH:C016276
16033898	941	968	8-(4-chlorophenylthio)-cGMP	Chemical	-
16033898	982	987	Abeta	Gene	351
16033898	1026	1029	cGK	Gene	5592
16033898	1104	1108	CREB	Gene	1385
16033898	1167	1172	Abeta	Gene	351
16033898	1193	1198	Abeta	Gene	351
16033898	1222	1226	cGMP	Chemical	MESH:D006152
16033898	1285	1291	DEA/NO	Chemical	-
16033898	1318	1323	Abeta	Gene	351
16033898	1411	1416	Abeta	Gene	351
16033898	1438	1442	cGMP	Chemical	MESH:D006152
16033898	1443	1446	cGK	Gene	5592
16033898	1447	1451	CREB	Gene	1385
16033898	1489	1493	cGMP	Chemical	MESH:D006152
16033898	1553	1555	AD	Disease	MESH:D000544
16033898	1566	1592	neurodegenerative diseases	Disease	MESH:D019636
16033898	1621	1626	Abeta	Gene	351
16033898	Negative_Correlation	351	5592
16033898	Positive_Correlation	MESH:C016276	5592
16033898	Positive_Correlation	MESH:C423582	5592
16033898	Negative_Correlation	MESH:C423582	351
16033898	Negative_Correlation	1385	351
16033898	Association	MESH:D006152	MESH:D019636
16033898	Association	MESH:D006152	1385
16033898	Association	MESH:D006152	MESH:D000544
16033898	Association	MESH:D000544	351
16033898	Association	MESH:D006152	5592
16033898	Negative_Correlation	MESH:D006152	351

